SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-007149
Filing Date
2023-04-28
Accepted
2023-04-28 07:07:29
Documents
121
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F rdhl-20221231x20f.htm   iXBRL 20-F 3800192
2 EX-1.1 rdhl-20221231xex1d1.htm EX-1.1 301981
3 EX-4.9 rdhl-20221231xex4d9.htm EX-4.9 134470
4 EX-4.10 rdhl-20221231xex4d10.htm EX-4.10 188193
5 EX-4.11 rdhl-20221231xex4d11.htm EX-4.11 112422
6 EX-4.21 rdhl-20221231xex4d21.htm EX-4.21 144813
7 EX-4.25 rdhl-20221231xex4d25.htm EX-4.25 410685
8 EX-12.1 rdhl-20221231xex12d1.htm EX-12.1 13416
9 EX-12.2 rdhl-20221231xex12d2.htm EX-12.2 15448
10 EX-13 rdhl-20221231xex13.htm EX-13 8991
11 EX-15.1 rdhl-20221231xex15d1.htm EX-15.1 6616
12 GRAPHIC rdhl-20221231x20f009.jpg GRAPHIC 2080
13 GRAPHIC rdhl-20221231xex15d1001.jpg GRAPHIC 3033
14 GRAPHIC rdhl-20221231xex4d10001.jpg GRAPHIC 5198
15 GRAPHIC rdhl-20221231xex4d11001.jpg GRAPHIC 4336
  Complete submission text file 0001558370-23-007149.txt   14857237

Data Files

Seq Description Document Type Size
16 EX-101.SCH rdhl-20221231.xsd EX-101.SCH 106951
17 EX-101.CAL rdhl-20221231_cal.xml EX-101.CAL 60479
18 EX-101.DEF rdhl-20221231_def.xml EX-101.DEF 339995
19 EX-101.LAB rdhl-20221231_lab.xml EX-101.LAB 701098
20 EX-101.PRE rdhl-20221231_pre.xml EX-101.PRE 554181
115 EXTRACTED XBRL INSTANCE DOCUMENT rdhl-20221231x20f_htm.xml XML 2545988
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-35773 | Film No.: 23860111
SIC: 2834 Pharmaceutical Preparations